RestoredCDC.org Comparison

    Original site: www.cdc.gov/global-health/countries/india.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
    [More]
    About Us Report Bug Compare Content
  Skip directly to site content Skip directly to search Skip directly to On This Page
          An official website of the United States government
        Here's how you know
              Official websites use .gov
              A .gov website belongs to an official government organization in the United States.
              Secure .gov websites use HTTPS
              A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
        Global Health
          Explore Topics
        Search
          Search
          Clear Input
        For Everyone
          * About the Global Health Center
          * CDC's Global Health Strategic Framework
          * A-Z Index
          * Leadership
          * Divisions and Offices
          * Communication Materials
          * Annual Report 2024
          * Reports and Publications
          * Our Success Stories
          * Careers
          * Where We Work
          * Regional Offices
          * Global Health Observances
          * Our Newsletter
          * View all
          Related Topics:
            Global Immunization | Global HIV and TB | Global Health Protection | Global Health Equity
            Global Immunization | Global HIV and TB | Global Health Protection
        View All
      search close search
          search
    Global Health Menu Close
    Global Health Menu
          search
              For Everyone
                  * About the Global Health Center
                  * CDC's Global Health Strategic Framework
                  * A-Z Index
                  * Leadership
                  * Divisions and Offices
                  * Communication Materials
                  * Annual Report 2024
                  * Reports and Publications
                  * Our Success Stories
                  * View All Home
              Related Topics
                  * Global Immunization
                  * Global HIV and TB
                  * Global Health Protection
                  * Global Health Equity
        View All Global Health
    About the Global Health Center CDC's Global Health Strategic Framework A-Z Index Leadership Divisions and Offices Communication Materials Reports and Publications Our Success Stories View All
    About the Global Health Center CDC's Global Health Strategic Framework A-Z Index Leadership Divisions and Offices Communication Materials Annual Report 2024 Reports and Publications View All
November 15, 2024
  CDC in India
          At a glance
          CDC works with the Ministry of Health and Family Welfare and other partners to build effective public health collaboration and partnerships, which strengthen the country's core public health capabilities: data and surveillance, laboratory capacity, workforce and institutions, prevention and response, innovation and research, and policy, communications, and diplomacy.
        Overview
          View Larger
          A woman holds her infant as a nurse prepares a vaccine during Village Health and Nutrition Day at an integrated center for child development in India.
          SOURCE:
          © UNICEF/U.S. CDC/UNI421369/Ahmad
        CDC has worked in India for over 50 years. CDC India works closely with the Ministry of Health and Family Welfare and partner organizations to detect, prevent and control infectious disease outbreaks and build and strengthen the country's core public health capabilities. These include data and surveillance, laboratory capacity, workforce and institutions, prevention and response, innovation and research, and policy, communications, and diplomacy. CDC's work aims to protect the health of our nations and public health around the world.
        Improving public health systems
        CDC supports global health security priorities in India by providing technical expertise in strengthening public health systems to prevent, detect, and respond to emerging infectious diseases. Efforts include:
          * Evidence-based technical guidance for Integrated Public Health Laboratory (IPHL)
          * Leading One Health efforts to adapt training programs
          * Prioritizing infectious disease implementation
          * Strengthening surveillance and reporting for AMR
        CDC has supported training for over 20,000 workers in epidemiology and disease surveillance, public health emergency management, laboratory diagnostic testing, and biosafety and quality management.
        Laboratory systems
        CDC is collaborating with Government of India (GoI) to develop a tiered lab network capable of detecting emerging and novel pathogens such as Nipah, influenza and others. CDC supports GoI initiatives to improve and serve as a regional leader in:
          * Diagnostic capabilities
          * Quality management systems
          * Biosafety and biosecurity practices
          * Specimen referral and transport
          * Genomic surveillance
        Key achievements
          * Strengthened molecular detection capabilities for emerging pathogens.
          * Developed and implemented IPHLs and their scale-up across all 730 districts. IPHLs have streamlined district and block level lab practices and increased lab diagnostic capacity.
          * Trained in the application of evidence-based techniques for sub-district, district, and state referral labs.
          * Supported the National Institute of Epidemiology to build capacity for whole genome sequencing of antimicrobial-resistant bacteria.
        Workforce development
        CDC's Field Epidemiology Training Program (FETP) strengthens the public health workforce's abilities to detect, respond, and control disease outbreaks at the source. To meet international health regulation targets, India needs to train over 7,000 epidemiologists. To help achieve this goal, CDC supported the establishment of an advanced FETP, India Epidemic Intelligence Service (India EIS) in 2012. Since then, India FETP has expanded to three hubs, training over 200 officers per year, across three FETP tiers (advanced, intermediate, and frontline). Since 2012, India FETP officers investigated over 550 outbreaks and conducted over 300 surveillance evaluations.
        Key accomplishments
          * Championed the development and release of a "One-India" FETP Roadmap, which lays the vision for FETP in India.
          * Supported India FETP in launching two new initiatives to support FETP faculty development – an India EIS faculty cohort and a two-year public health workforce fellowship.
          * Provided support to 'SectorConnect' (a One-Health Frontline FETP) and a one-year informatics program (Growing Experience in E-Learning and Knowledge, or GEEKS).
          * Collaborated with GoI, WHO, and the South Asia Field Epidemiology Training Network to develop an India FETP learning management system platform. The platform will be instrumental in expanding a cadre of highly skilled field epidemiologists through a scalable learning approach.
        Emergency management
        CDC collaborates with GoI to enhance India's emergency management capabilities and resilience. Through national technical working groups, CDC provides technical assistance to implement modern emergency management concepts and principles, using a common framework for public health response, and exercises for pandemic preparedness. CDC aims to:
          * Increase emergency management human resource capacity
          * Strengthen national and sub-national emergency operations centers (EOCs)
          * Develop and update emergency response plans, protocols, and procedures
          * Build and sustain crisis and risk communication capacity
          * Enhance points of entry preparedness and response capabilities
          * Train and equip rapid response teams with management and operations competence
          * Offer real-time support for multiple activations of EOCs and outbreak response systems
        Key accomplishments
          * Supported the establishment, operation, and management of national and sub-national EOCs that can coordinate and direct response to disease outbreaks, natural or humanmade disasters, and other public health emergencies.
          * Collaborated to create, develop, establish, and maintain a comprehensive five-tiered Public Health Emergency and Disaster Management Professional Development Program. This program aims to develop preparedness and response capacity for the entire spectrum of the response workforce, from community members to professionals and policymakers.
          * Support training for multisectoral personnel to effectively respond to public health emergencies and disasters, thereby fostering the development of a strong, adaptable, and resilient emergency management workforce.
        Antimicrobial resistance (AMR)
        CDC has been supporting the National Center for Disease Control (NCDC), GoI, to establish the National Antimicrobial Surveillance Network (NARS-NET) to improve quality assured testing, standardize scopes of practice, and conduct trainings. NARS-NET has increased from 10 laboratories in 2013 to include 50 laboratories across 27 states and 6 union territories.
        CDC has been supporting the National Center for Disease Control (NCDC), GoI, to establish the National Antimicrobial Surveillance Network (NARS-NET) to improve quality assured testing, standardize scopes of practice, and conduct trainings. NARS-NET has increased from 10 laboratories in 2013 to include 60 laboratories across 27 states and 6 union territories.
        CDC supports NCDC in strengthening the state level AMR surveillance networks. This support includes training and conducting reviews in seven Indian states. CDC supports AIIMS in partnership with the Indian Council for Medical Research to develop and implement a network for surveillance and prevention of healthcare associated infections.
        Key accomplishments
          * More than 200 intensive care units report to AIIMS. These reports include nearly 60 hospitals that conduct surveillance for bloodstream infections, urinary tract infections, and surgical site infections. An additional 40 medical college hospitals are enrolled through the NCDC, and 750 district hospitals across the country will be enrolled to the network.
          * AIIMS prepares and and shares quarterly reports with Ministry of Health and Family Welfare (MoHFW) and key stakeholders, including WHO.
          * Through CDC support, the network uses virtual training programs to build capacity to reduce HAIs and improve infection prevention and control programs using quality improvement methodology.
          * Contribute to NCDC, GOI technical advisory and core working groups on AMR, infection prevention and control, and Antimicrobial Stewardship Program to develop and implement a National Action Plan on Antimicrobial Resistance.
        HIV
        In collaboration with GoI, CDC is improving access to comprehensive HIV prevention, testing, and treatment care continuum for priority and key populations. CDC efforts and key accomplishments are outlined below.
        In collaboration with GoI, CDC is improving access to comprehensive HIV prevention, testing, and treatment care continuum for people at higher risk of acquiring HIV. CDC efforts and key accomplishments are outlined below.
        Prevention and case finding
          * Integrated service delivery strategies by establishing community one stop centers, motor bike interventions, and service delivery strategies for people who migrate.
          * Supported a free mobile application of the national HIV treatment guidelines.
          * Expanded evidence-based case finding strategies, including index testing services, and social network strategy. These strategies have been included in the revised national HIV counseling and testing guidelines.
          * Supported training for 430 master trainers in index testing services. These master trainers coordinated cascade trainings for over 5,772 healthcare workers (5,000 ICTC and 772 ART center staff.)
        Treatment
          * Influential in drafting the national operational guidelines for antiretroviral treatment (ART) services and national guidelines for HIV care and treatment. These guidelines were disseminated to staff from 772 ART centers and 29 state AIDS control societies.
          * Developed a curriculum for training of antiretroviral therapy centre staff and trained a pool of 120 master trainers to cascade the training to staff from 772 centres.
          * Partnered to integrate strategies that address non-communicable diseases for people living with HIV (PLHIV). This includes screening and management of cervical cancer, hypertension, diabetes and mental health, into HIV care to ensure treatment continuity.
          * Supported demonstration of the full package of HIV Advanced Disease Management package (ADM) including point of care screening of TB and cryptococcus (a fungal infection.)
        Lab strengthening
          * Integrated diagnostic network strategies, network optimization, and workforce development to strengthen the HIV viral load test capacity to provide annual viral load tests to 1.4 million PLHIV receiving treatment at 772 ART centers.
          * Supported technology transfer for the HIV-1 testing proficiency program with successful expansion to 64 molecular labs.
          * Supported NACO's laboratory quality assurance and accreditation flagship program since 2009 and call for 100% of ISO 15189 accreditation for all the 250 HIV, viral load and early infant diagnosis labs.
          * Provided technical assistance to strengthen the STI lab network across 10 regional sexually transmitted infections (STI) labs and provide quality assured etiological diagnosis and drug resistance profiling.
          * Collaborated with NACO and Global Fund partners to develop HIV drug resistance diagnostic capacities in India.
          * Demonstrated the full HIV Advanced Disease Management package, including point-of- care screening of TB and cryptococcus.
        Strategic information
          * CDC supports NACO's framework for integrated and enhanced epidemiology and surveillance for HIV, STIs, and comorbidities. This includes support for HIV estimates, India's nationwide HIV behavioral sentinel surveillance — the largest in the world— and integrated biological and behavioral surveillance among key populations.
        TB
        CDC supports the National Tuberculosis Elimination Program (NTEP) to end TB by supporting four strategic pillars: detect, treat, prevent, and strengthen capacity. CDC efforts and key accomplishments are outlined below.
        Prevention and treatment
        CDC successfully implemented "Strengthening TB Action and Response (STAR)" project in Mumbai to:
          * Provide public sector drug susceptibility testing support to start individualized drug-resistant TB (DR TB) treatment
          * Improve DR TB treatment adherence
          * Strengthen TB infection prevention and control (IPC) practices to reduce TB transmission at 144 healthcare facilities
        This work was successfully scaled up in ten states as the 'TB Mukt Bharat IPC' project. The project is being implemented in 189 healthcare facilities in 63 districts across ten states of India.
          * Implemented the 'PrTHAM' project to prevent TB infection among healthcare workers through screening for TB and TB infection at Mahatma Gandhi Institute of Medical Sciences and Kasturba hospital in Sevagram, Maharashtra.
          * During the COVID-19 pandemic, CDC-supported Dharavi project that improved treatment outcomes among patients with DRTB in Mumbai's informal urban settlements. The project retained nearly all patients on treatment, even those who migrated elsewhere.
          * Implemented early TB preventive treatment programs in India to diagnose and treat TB among household contacts in Nagpur and Mumbai, Maharashtra, using patient-friendly diagnostic tests and treatment regimens.
          * Supported NTEP to improve linkage to TB evaluation and treatment in children through the 'End TB in Indian Children' project in Delhi, Mumbai, and Chennai.
          * Provided technical support to ensure external quality assessment for rapid molecular tests. The NTEP plans eventually expanded the practice to cover all TB testing sites in India.
          * Provided capacity for next generation sequencing at the National Institute of Research in TB (NIRT) in Chennai. With CDC support, NIRT conducted NGS on a prospective cohort of patients with DR TB across India. This effort identified common and new TB mutations and led to the first Indian TB catalogue of mutations.
        Data management
          * Expanded ELEVATE (E2) project to strengthen state- and district-level capacity to use local data to guide programmatic actions and accelerate TB control and elimination efforts in 11 states across India.
          * Supported training a total of 767 NTEP staff across the states on data quality and analysis to support states' management for information to programmatic action.
        Influenza
        CDC helps India prepare for pandemics in alignment with India's "Pandemic Influenza Preparedness and Response Plan". CDC works to strengthen laboratories and training clinicians on effective case management and infection control. Strong influenza surveillance has enabled India to detect influenza seasonal peaks during monsoons, understand the seasonality of influenza in tropical countries, and guide timing for influenza vaccination.
        Key accomplishments
          * Collaborated with the All India Institute of Medical Sciences (AIIMS) to help determine the disease and economic burdens of influenza and other respiratory viruses in priority groups, evaluate effectiveness of influenza vaccines, and identify optimal timing for influenza vaccination.
          * Fostered collaboration in influenza prevention and control among diverse stakeholders, including government bodies, healthcare professionals, researchers, and professional organizations in India through multiple stakeholder meetings during 2022-23 period involving representatives from more than 15 states.
          * Advanced molecular diagnostic capacity developed during CDC's collaborations with National Institute of Virology. Efforts were made to scale up PCR SARS-CoV-2 testing across India's influenza laboratory network.
          * Strengthened the influenza surveillance network by building lab capacity for rapid detection of viruses and emerging pathogens. This includes building capacity for molecular diagnostics (RT-PCR and genetic sequencing) and providing critical supplies.
          * Supported trainings on Flu-COVID-19 RT-PCR and NGS for participants from medical colleges across India regions (Karnataka, Kerala, Andhra Pradesh, Rajasthan, Madhya Pradesh, Jammu & Kashmir, West Bengal, Sikkim, Meghalaya, and Assam).
        Vaccine-preventable diseases (VPDs)
        CDC supports efforts to eliminate or control vaccine-preventable diseases through the Universal Immunization Program. Since the mid 1990's, CDC has helped strengthen:
          * Epidemiology and laboratory methods
          * Routine immunization services
          * Training methods, data systems
          * Case-based disease surveillance
          * Outbreak preparedness and response
        CDC's support of the National Public Health Surveillance Project strengthened implementation of polio, measles, and COVID-19 vaccination campaigns, outbreak response, and surveillance.
        Fact sheet
                India Fact Sheet
                Download CDC's country fact sheet for India.
                Download the U.S. CDC fact sheet for India.
              Dec. 23, 2024
                  Download
                Download
        Success story spotlight
        Empowering community leaders among female sex workers for HIV service equity and addressing stigma
          To improve access to HIV treatment among female sex workers living with HIV, CDC provided on-site technical assistance.
        CDC India, in collaboration with the Society for Health Allied Research and Education INDIA (SHARE INDIA) and the Andhra Pradesh State AIDS Control Society (APSACS) worked to enhance HIV service delivery for female sex workers at NARI SAKSHAM, a community led organization in Rajahmundry, Andhra Pradesh. This organization reaches 2,700 female sex workers across the district through 100 community-based groups.
        Female sex workers have historically faced barriers in health care settings such as social exclusion, stigma, and discrimination. Additionally, a complex public health system with limited accessibility has led to poor patient outcomes, including irregular pick up of antiretroviral treatment (ART), lack of follow up, and lower adherence to treatment.
        To improve access to HIV treatment among female sex workers living with HIV, CDC provided on-site technical assistance to NARI SAKSHAM for establishing decentralized ART clinical services to ensure consistent treatment and durable viral load suppression. CDC trained community leaders on how to administer ART, regularly check on people living with HIV, collect samples for viral load tests, and report data. Through the Undetectable = Untransmittable (U=U) campaign, community leaders also promoted positive HIV treatment adherence and reducing stigma.
        G. Vijaya Rani, coordinator at NARI SAKSHAM, noted significant improvements: 981 people living with HIV, including 412 female sex workers received regular ART. "Earlier we didn't know if members were taking medicines regularly and if their health was okay. Now I can observe that they come regularly and take ART. I am also able to follow up on their VL test due dates and refer them for tests on time".
        From 2020 to 2022, the initiative achieved a 98% treatment retention rate for female sex workers with HIV, increased viral load testing access from 21% to 92%, and improved viral suppression from 77% to 94%. This model's success led to its adoption by 29 community-based organizations across Andhra Pradesh, setting a national benchmark for empowering communities and achieving HIV service equity.
        Success stories
                              Transforming TB Outcomes in India Through Data-Driven Solutions
                            Discover how CDC is harnessing data to help stop the world's deadliest infectious disease in India. Feb 26, 2025
                              Using Whole Genome Sequencing in India to Combat Antimicrobial Resistance Threats
                            Learn about CDC work with partners in India using whole genome sequencing to combat AR. Oct 18, 2024
                              Innovative Studies Investigate Spread of Antimicrobial Resistance in Communities and Hospitals
                            Antibiotic Resistance in Communities and Hospitals (ARCH) July 3, 2024
                              Photos from the Field
                            Photos of CDC and partners working on vaccination worldwide. May 16, 2024
                              A TB-Free India: Stopping TB before it Spreads
                            The TB Mukt Bharat Infection Prevention and Control project helped India address TB challenges. May 6, 2024
                              Aiming for Global TB Targets While Navigating a Pandemic
                            This story speaks to the challenges CDC faced navigating the TB and HIV epidemics during COVID-19. Mar 25, 2024
                              CDC Experts Help India Scale-up Laboratory Systems in Response to COVID-19's Second Wave
                            In India, the COVID-19 pandemic posed challenges. Mar 12, 2024
            View More
        Videos
                U.S. Embassy - CDC's work in India
                U.S. Embassy - U.S. CDC India HIV Prevention
        Publications
                India Anniversary Report
                Read CDC India's anniversary report.
              Aug. 13, 2024
                Progress Toward Measles and Rubella Elimination — India, 2005–2021
                MMWR. Morbidity and Mortality Weekly Report / Vol. 71 / No. 50 / P. 1569–1575
                Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic — Dharavi, Mumbai, India, 2020–2022
                MMWR. Morbidity and Mortality Weekly Report / Vol. 72 / No. 12 / P. 304–308
                India - Emerging Infectious Diseases (EID)
                Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India
                Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India
                India Field Epidemiology Training Program Response to COVID-19 Pandemic, 2020–2021
        On This Page
            * Overview
            * Improving public health systems
            * Antimicrobial resistance (AMR)
            * HIV
            * TB
            * Influenza
            * Vaccine-preventable diseases (VPDs)
            * Fact sheet
            * Success story spotlight
            * Success stories
            * Videos
            * Publications
          Show More
          Related Pages
              View All
        Back to Top
            * Where We Work
            * Guinea
            * Haiti
            * Indonesia
            * Kenya
          View All Global Health
    Indonesia
  November 15, 2024
      Sources Print Share
        Facebook LinkedIn Twitter Syndicate
          Content Source:
        Global Health Center
      Related Pages
          View All
 
        * Where We Work
        * Guinea
        * Haiti
        * Indonesia
        * Kenya
      View All Global Health
  Back to Top
    Global Health
    CDC's Global Health Center works 24/7 to reduce illness and respond to health threats worldwide.
    View All
          * About the Global Health Center
          * CDC's Global Health Strategic Framework
          * A-Z Index
          * Leadership
          * Divisions and Offices
          * Communication Materials
          * Annual Report 2024
          * Reports and Publications
          * Our Success Stories
          * Careers
          * Where We Work
          * Regional Offices
          * Global Health Observances
          * Our Newsletter
          * View All
        Sign up for Email Updates
    Contact Us
        Contact Us
          * Call 800-232-4636
          * Contact CDC
    About CDC
        About CDC
          * Pressroom
          * Organization
          * Budget & Funding
          * Careers & Jobs
    Policies
              * Accessibility
              * External Links
              * Privacy
              * Web Policies
              * FOIA
              * OIG
              * No Fear Act
              * Nondiscrimination
              * Vulnerability Disclosure Policy
    Languages
            Languages
              * Español
            Language Assistance
                  * Español
                  * 繁體中文
                  * Tiếng Việt
                  * 한국어
                  * Tagalog
                  * Русский
                  * العربية
                  * Kreyòl Ayisyen
                  * Français
                  * Polski
                  * Português
                  * Italiano
                  * Deutsch
                  * 日本語
                  * فارسی
                  * English
    Archive
          * CDC Archive
          * Public Health Publications
    Contact Us
      Contact Us
        * Call 800-232-4636
        * Contact CDC
    About CDC
        * Pressroom
        * Organization
        * Budget & Funding
        * Careers & Jobs
        * About CDC
    Policies
        * Accessibility
        * External Links
        * Privacy
        * Web Policies
        * FOIA
        * OIG
        * No Fear Act
        * Nondiscrimination
        * Vulnerability Disclosure Policy
    Languages
      Languages
        * Español
      Language Assistance
        * Español
        * 繁體中文
        * Tiếng Việt
        * 한국어
        * Tagalog
        * Русский
        * العربية
        * Kreyòl Ayisyen
        * Français
        * Polski
        * Português
        * Italiano
        * Deutsch
        * 日本語
        * فارسی
        * English
    Archive
        * CDC Archive
        * Public Health Publications
    HHS.gov USA.gov